Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Telix submits CTA to begin phase III trial in Europe with TLX-250 for renal cancer imaging

Aug. 24, 2018

First patients imaged in phase II expanded access study of 68Ga-PSMA-11

Aug. 13, 2018

Evaluation of [11C]BU-99008 as a marker for AD pathology mechanisms

July 26, 2018

Phase 0 results presented for tau-imaging tracer [18F]JNJ-067

July 26, 2018

Synaptic vesicle glycoprotein 2A by PET imaging, a marker of synaptic density in Alzheimer's disease

July 20, 2018

Selective PDE4D PET ligands developed to study depression and cognitive impairment

July 19, 2018

Discovery of novel PET tracer for imaging CSF-1R in the brain

July 18, 2018

Discovery of [18F]SWR-4-127, a novel PARP-1 selective 18F-PET tracer for neuroimaging

July 16, 2018

Yale University develops novel SV2A radiotracer for PET imaging of synaptic density

July 13, 2018

Phase I trial of OncoNano's tumor imaging agent ONM-100 begins

July 13, 2018

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026